T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.84B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.13B |
| 3 |
Elanco Animal Health
ELAN
|
+$1.1B |
| 4 |
Bank of America
BAC
|
+$860M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$618M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.19B |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$1.55B |
| 3 |
JPMorgan Chase
JPM
|
+$1.29B |
| 4 |
Booking.com
BKNG
|
+$1.06B |
| 5 |
Merck
MRK
|
+$757M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Healthcare | 18.48% |
| 3 | Consumer Discretionary | 13.62% |
| 4 | Financials | 13.47% |
| 5 | Communication Services | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Mettler-Toledo International
MTD
$30.8B
| $116M | 0.02% |
160,575
-9,491
| -6% | -$6.17M |
|
602
MKS Inc
MKSI
$17.4B
| $115M | 0.02% |
1,240,904
-87,924
| -7% | -$7.09M |
|
603
Minerals Technologies
MTX
$2.09B
| $114M | 0.02% |
1,939,910
+35,420
| +2% | +$2.02M |
|
604
Helios Technologies
HLIO
$2.27B
| $113M | 0.02% |
2,433,867
+103,536
| +4% | +$4.14M |
|
605
Phillips 66
PSX
$101B
| $113M | 0.02% |
1,185,555
+33,433
| +3% | +$3.18M |
|
|
HTO
606
H2O America
HTO
$2.56B
| $113M | 0.02% |
1,826,464
-42,921
| -2% | -$2.58M |
|
607
Moog Inc Class A
MOG.A
$12.5B
| $111M | 0.02% |
1,281,472
+5,382
| +0.4% | +$469K |
|
|
PARA
608
DELISTED
Paramount Global Class B
PARA
| $111M | 0.02% |
2,336,972
+35,237
| +2% | +$1.72M |
|
609
US Physical Therapy
USPH
$1.3B
| $111M | 0.02% |
1,054,050
-12,253
| -1% | -$1.32M |
|
|
DISH
610
DELISTED
DISH Network Corp.
DISH
| $111M | 0.02% |
3,487,832
+2,237,634
| +179% | +$68.5M |
|
611
SouthState Bank Corp
SSB
$9.88B
| $110M | 0.02% |
1,613,476
-1,384
| -0.1% | -$93K |
|
612
FTI Consulting
FCN
$3.68B
| $110M | 0.02% |
1,432,135
-11,972
| -0.8% | -$845K |
|
|
NUVA
613
DELISTED
NuVasive, Inc.
NUVA
| $110M | 0.02% |
1,931,757
-214,224
| -10% | -$11.4M |
|
614
Coca-Cola Consolidated
COKE
$12.7B
| $109M | 0.02% |
3,781,060
+32,210
| +0.9% | +$736K |
|
615
Steven Madden
SHOO
$3.27B
| $108M | 0.02% |
3,183,136
-31,638
| -1% | -$1.03M |
|
616
Heritage Financial
HFWA
$1.15B
| $108M | 0.02% |
3,567,470
-32,323
| -0.9% | -$1.01M |
|
617
TherapeuticsMD
TXMD
$23.6M
| $107M | 0.02% |
440,041
+9,594
| +2% | +$2.54M |
|
618
Guardant Health
GH
$24B
| $107M | 0.02% |
1,415,212
+8,916
| +0.6% | +$494K |
|
|
STFC
619
DELISTED
State Auto Financial Corp
STFC
| $107M | 0.02% |
3,242,726
+163,681
| +5% | +$5.55M |
|
620
PRA Group
PRAA
$755M
| $107M | 0.02% |
3,978,375
-124,978
| -3% | -$3.61M |
|
|
SGI
621
Somnigroup International
SGI
$13.3B
| $106M | 0.02% |
7,362,292
+975,388
| +15% | +$13.2M |
|
|
ONC
622
BeOne Medicines Ltd
ONC
$41.5B
| $106M | 0.02% |
802,338
-147,359
| -16% | -$19.9M |
|
|
TPH
623
DELISTED
Tri Pointe Homes
TPH
| $105M | 0.02% |
8,336,128
-229,417
| -3% | -$2.92M |
|
|
ZNGA
624
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $105M | 0.02% |
19,757,704
-4,593,947
| -19% | -$22.1M |
|
|
AIMT
625
DELISTED
Aimmune Therapeutics
AIMT
| $105M | 0.02% |
4,711,532
-60,377
| -1% | -$1.42M |
|
Similar funds
T. Rowe Price Associates's Q1 2019 Portfolio in Review
As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q1 2019 filing shows 56 new, 1,633 increased, 713 reduced and 86 closed positions. Its largest new stake was Fox Class B: 11,707,204 shares worth $420M. The largest sale was Tesla, an estimated $2.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
- T. Rowe Price Associates's biggest Q1 2019 reduction was Tesla, cutting an estimated $2.19B.
- T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
- T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
- T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.